Cases Investigated

Beasley Allen is currently investigating the following cases involving medical devices and drugs. However, our attorneys would like to investigate any claims of serious injury or death that may be the result of defective medical devices or drugs.

$2.4 Billion Actos Bladder Cancer Settlement Explained

September 28, 2015 - Beasley Allen principal Frank Woodson discusses the recent $2.4 billion Actos settlement on Ringler Radio. Read More

Lawsuits claim talcum powder products caused ovarian cancer

August 3, 2015 - Johnson & Johnson refuses to warn women that its talc containing products, like Johnson’s Baby Powder and Shower to Shower, can cause ovarian cancer despite four decades of studies... Read More

Xarelto’s risks outweigh the benefits: Beasley Allen principal David Byrne explains

July 16, 2015 - Xarelto is in a new class of blood thinners designed to be an alternative to warfarin for the treatment of blood clots; however, unlike warfarin, there is no antidote to reverse the blood... Read More

Jury awards $100 million to woman injured by transvaginal mesh

May 29, 2015 - A Delaware jury ordered Boston Scientific Corp. to pay a Newark woman a record $100 million in damages for injuries she suffered from the company’s transvaginal mesh device. Read More

Beasley Allen, lawyers named to Chambers USA list for excellence

May 19, 2015 - Beasley Allen law firm and three of our attorneys have been named to the Chamber USA list of best lawyers in America. Chambers' intensive, continuous research identifies the world’s... Read More

$2.4 billion settlement agreement reached in Actos bladder cancer litigation

April 29, 2015 - Takeda Pharmaceutical Co. has agreed to a $2.4 billion settlement to resolve bladder cancer claims tied to its Type 2 diabetes drug Actos. The settlement will compensate an anticipated... Read More

Blood thinner Xarelto dangers discussed by Beasley Allen attorney David Byrne

February 24, 2015 - Today on the Beasley Allen Report, host Gibson Vance interviews fellow Beasley Allen attorney David Byrne on the dangers of the prescription drug Xarelto. Read More

Beasley Allen lawyer Andy Birchfield appointed to leadership role in Xarelto blood thinner multidistrict litigation

February 10, 2015 - Beasley Allen Mass Torts section head Andy Birchfield has been appointed as Co-Lead Counsel for the Plaintiffs Steering Committee (PSC) in multidistrict litigation (MDL) over blood-thinner... Read More

Beasley Allen names Dearing, Mason, Teague and Lampkin as new Principals

January 14, 2015 - Beasley Allen has named four attorneys as new Principals: David Dearing, James Lampkin, Danielle Ward Mason, and Matt Teague. All four lawyers work in the firm’s Mass Torts Section. Read More

Beasley Allen lawyer Navan Ward and family spotlighted in WynLiving magazine

January 6, 2015 - Navan Ward, a Principal in our Mass Torts section, and his family were recently featured in WynLiving, the magazine serving residents of the Wynlakes and Wyndridge neighborhoods in... Read More

Fields marked    may be required for submission.
  1. I'm an attorney
back to top